Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingre Huatan Formula for Early Neurological Deterioration in Acute Ischemic Stroke
NCT06857487Phase 2Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jun 2025
- Primary completion
- Oct 2026
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Qingfei Huatan Fang in ischemic stroke, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Started Jun 2025; status: recruiting.
02
Drugs
Qingfei Huatan Fang
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06857487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06857487.